Suzanne  E.  Schindler, MD, PhD

Suzanne E. Schindler, MD, PhD

Fluid Biomarker Core Leader
Principal Investigator
Associate Professor of Neurology

Click to see this content

Suzanne Schindler, MD, PhD, is a clinical neurologist and neuroscientist focused on improving the diagnosis and treatment of Alzheimer disease. She completed the MD/PhD program at Washington University, where she studied the basic biology of apolipoprotein E (apoE) metabolism in the laboratory of David Holtzman, MD. Schindler then trained in clinical neurology at Washington University and completed a fellowship in dementia under the mentorship of Drs. John Morris, Marc Diamond and Anne Fagan. Currently Schindler sees patients with memory concerns in a weekly clinic, coordinates lumbar punctures for patients seen in the memory clinic and attends on the neurology consult service one month per year. She also performs detailed research assessments for the Knight Alzheimer Disease Research Center. She has been involved in multiple clinical trials, including the first prevention drug trial for Alzheimer disease. Schindler received a career development award from the National Institute on Aging to study cerebrospinal fluid biomarkers of Alzheimer disease. She received a large R01 to evaluate the relationship between plasma biomarkers and symptomatic Alzheimer disease. She is very interested in translating research findings into clinical practice. Further, she has a particular focus on understanding and reducing disparities in healthcare.